Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P. Golando"'
Publikováno v:
Advances in Space Research. 36:2474-2479
Two missions presently under development by the United States Air Force Academy (USAFA), FalconSAT-2 and FalconSAT-3, include mission scientific objectives targeting the study of ionospheric F region plasma density depletions and topside bubbles asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a06b5483e5e30d53dfde9c143f43a22
https://doi.org/10.1016/j.asr.2004.03.020
https://doi.org/10.1016/j.asr.2004.03.020
Autor:
Kenneth Beougher, Eric M. Bonnem, Daniel D. VonHoff, Jim M. Koeller, James P. Golando, T. D. Brown
Publikováno v:
Journal of Oncology Pharmacy Practice. 2:22-28
Objective: To determine the maximally tolerated dose and associated toxicity of r-γ-IFN. In addition, to evaluate the development of serum IFN neutralizing factors. Design: This is an open-labeled, Phase I dose escalating trial.Setting: This trial w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dad23f5d682f1dc967085ee08b31d30
https://doi.org/10.1177/107815529600200103
https://doi.org/10.1177/107815529600200103
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer. 59:620-625
The activity of the alpha interferons against AIDS-related Kaposi's sarcoma (KS) has been demonstrated in numerous clinical trials. Unfortunately, most reports have involved small patient cohorts and a variety of dosages and schedules of administrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e006ce2d42d398967ad454fca27c676a
https://doi.org/10.1002/1097-0142(19870201)59:3+<620::aid-cncr2820591309>3.0.co
https://doi.org/10.1002/1097-0142(19870201)59:3+<620::aid-cncr2820591309>3.0.co
Autor:
Koeller, Jim, Brown, Thomas D., Beougher, Kenneth, Golando, James, Bonnem, Eric M., VonHoff, Daniel D.
Publikováno v:
Journal of Oncology Pharmacy Practice; March 1996, Vol. 2 Issue: 1 p22-28, 7p
Publikováno v:
Cancer. 59
The activity of the alpha interferons against AIDS-related Kaposi's sarcoma (KS) has been demonstrated in numerous clinical trials. Unfortunately, most reports have involved small patient cohorts and a variety of dosages and schedules of administrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ce20a3466882a07a6eab3fcb1ff8d09
https://pubmed.ncbi.nlm.nih.gov/3492260
https://pubmed.ncbi.nlm.nih.gov/3492260
Autor:
G A, Sarosy, T D, Brown, D D, Von Hoff, R J, Spiegel, J P, Golando, K L, Beougher, J G, Kuhn, D L, Kisner
Publikováno v:
Cancer research. 46(10)
Cytotoxic chemotherapy and interferon have shown synergistic antitumor activity in vitro. The purpose of this study was to determine the maximally tolerated dose of doxorubicin given every 3 weeks, in patients receiving recombinant alpha 2-interferon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29ed07af9d3530535a201acb85f660e6
https://pubmed.ncbi.nlm.nih.gov/3756887
https://pubmed.ncbi.nlm.nih.gov/3756887
Autor:
D. D. Von Hoff, James P. Golando, K. Beougher, Jim M. Koeller, T. D. Brown, Eric M. Bonnem, R. J. Spiegel
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 5(5)
Recombinant gamma interferon (r-GIFN) demonstrates in vitro and in vivo characteristics that contrast with those of alpha and beta interferons. It has relatively weak antiviral properties, yet relatively potent immunomodulatory effects. A phase I tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317b40c286570400f67af5f87f25dff2
https://pubmed.ncbi.nlm.nih.gov/3106584
https://pubmed.ncbi.nlm.nih.gov/3106584